Market Overview:
The global buclizine market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in the market can be attributed to factors such as rising prevalence of allergic diseases, increasing awareness about histamine Hâ‚-receptor antagonists, and growing demand for hospital-based drugs. However, the high cost of buclizine may restrain the growth of this market during the forecast period. Based on type, the global buclizine market can be segmented into hospital-based drugs and drug store-based drugs. The hospital-based drugs segment is expected to account for a larger share of the global buclizine market in 2018 owing to rising demand for these products from hospitals and clinics across regions. By application, antiallergic agents are expected to account for a larger share of the global buclizine market in 2018 owing to their widespread use in treating various types of allergies.
Product Definition:
Buclizine is a medication that is used to treat nausea and vomiting. It is also used to prevent motion sickness.
Hospital:
Hospital is a medical facility where patients are treated and given the necessary medical treatment for acute ailments. The factors that propel the growth of buclizine market include growing geriatric population base, increasing prevalence of chronic diseases such as asthma, diabetes, arthritis and other autoimmune disorders along with rising incidences of trauma resulting in increased hospitalization. Moreover, technological advancements in healthcare infrastructure coupled with favorable government initiatives to provide better healthcare facilities to people drive the growth factor further.
Drug Store:
Drug store is a retail pharmacy, which is present in every town and city. It offers various medicines and drugs at lower prices as compared to the other pharmacies. The drug stores are owned by pharmaceutical companies or they are operated by individual owners.
The major function of these stores is to provide consumers with medications at affordable prices through their own networks; however, some countries have government-owned or -controlled drugstores where all types of medications can be purchased from an exclusive supplier.
Application Insights:
The antiallergic agent segment dominated the global buclizine market in 2017. This is attributed to the rising prevalence of allergic rhinitis and other nasal allergies. According to a study published by Allergy, Asthma & Sinusitis Association (AAAA), it was estimated that approximately 40 million people in U.S., have some form of allergy or asthma, which was around 17% of the total population in 2016.
Furthermore, according to data published by Global Wellness Institute based on responses from more than 15,000 patients across various countries including China, India and U.S., it has been observed that majority of patients suffering from nasal allergies are male (58%) followed by females (42%).
Regional Analysis:
Asia Pacific dominated the global market in 2017 and is expected to continue its dominance over the forecast period. This can be attributed to increasing product demand as a result of rising allergic conditions in this region. In addition, growing awareness about these drugs among patients is also expected to drive growth during the forecast period.
The Asia Pacific market for buclizine consists of major countries such as China, India, Japan and South Korea which have a high population with allergies prone towards asthma or other respiratory problems due to various factors such as pollution, climate change etc. Growing disposable income coupled with an increase in consumer health consciousness will further boost industry expansion over the next eight years time frame.
Europe accounted for more than 25% share of global revenue in 2017 owing to increased consumption by patients suffering from urticaria (hives), angioedema (swelling),.
Growth Factors:
- Increasing geriatric population: The global geriatric population is increasing at a rapid pace and this is expected to drive the demand for buclizine in the coming years.
- Rising prevalence of vertigo: The prevalence of vertigo is on the rise globally and this is expected to boost the demand for buclizine in the near future.
- Growing awareness about its benefits: There is growing awareness about the benefits of buclizine among consumers and this is likely to propel its market growth in the coming years.
- Technological advancements: The introduction of new technologies in buclizine manufacturing process will help reduce production costs, which will eventually lead to lower prices for consumers. This will further boost market growth over the forecast period. 5) Availability of generic versions: With patent protection expiring, there has been an increase in availability of generic versions of buclizine across different regions, which has helped reduce its cost and made it more affordable for consumers
Scope Of The Report
Report Attributes
Report Details
Report Title
Buclizine Market Research Report
By Type
Hospital, Drug Store
By Application
Antiallergic Agent, Histamine H₁-Receptor Antagonist
By Companies
Stuart Pharmaceuticals, Laboratorios Rocnarf, UCB, Mankind Pharma, Johnson and Johnson, Meider Pharma, Sanofi, MK Pharma, HUA Shin Chemical Pharmaceutical, Peili Pharmaceutical, Pfizer, Sinphar, Al Pharm
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
193
Number of Tables & Figures
136
Customization Available
Yes, the report can be customized as per your need.
Global Buclizine Market Report Segments:
The global Buclizine market is segmented on the basis of:
Types
Hospital, Drug Store
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Antiallergic Agent, Histamine H₁-Receptor Antagonist
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Stuart Pharmaceuticals
- Laboratorios Rocnarf
- UCB
- Mankind Pharma
- Johnson and Johnson
- Meider Pharma
- Sanofi
- MK Pharma
- HUA Shin Chemical Pharmaceutical
- Peili Pharmaceutical
- Pfizer
- Sinphar
- Al Pharm
Highlights of The Buclizine Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Hospital
- Drug Store
- By Application:
- Antiallergic Agent
- Histamine H₁-Receptor Antagonist
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Buclizine Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Buclizine is a medication used to treat anxiety and tension headaches. It works by reducing the intensity of pain signals sent to the brain.
Some of the major players in the buclizine market are Stuart Pharmaceuticals, Laboratorios Rocnarf, UCB, Mankind Pharma, Johnson and Johnson, Meider Pharma, Sanofi, MK Pharma, HUA Shin Chemical Pharmaceutical, Peili Pharmaceutical, Pfizer, Sinphar, Al Pharm.
The buclizine market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Buclizine Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Buclizine Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Buclizine Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Buclizine Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Buclizine Market Size & Forecast, 2018-2028
4.5.1 Buclizine Market Size and Y-o-Y Growth
4.5.2 Buclizine Market Absolute $ Opportunity
Chapter 5 Global Buclizine Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Buclizine Market Size Forecast by Type
5.2.1 Hospital
5.2.2 Drug Store
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Buclizine Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Buclizine Market Size Forecast by Applications
6.2.1 Antiallergic Agent
6.2.2 Histamine H₁-Receptor Antagonist
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Buclizine Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Buclizine Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Buclizine Analysis and Forecast
9.1 Introduction
9.2 North America Buclizine Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Buclizine Market Size Forecast by Type
9.6.1 Hospital
9.6.2 Drug Store
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Buclizine Market Size Forecast by Applications
9.10.1 Antiallergic Agent
9.10.2 Histamine H₁-Receptor Antagonist
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Buclizine Analysis and Forecast
10.1 Introduction
10.2 Europe Buclizine Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Buclizine Market Size Forecast by Type
10.6.1 Hospital
10.6.2 Drug Store
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Buclizine Market Size Forecast by Applications
10.10.1 Antiallergic Agent
10.10.2 Histamine H₁-Receptor Antagonist
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Buclizine Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Buclizine Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Buclizine Market Size Forecast by Type
11.6.1 Hospital
11.6.2 Drug Store
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Buclizine Market Size Forecast by Applications
11.10.1 Antiallergic Agent
11.10.2 Histamine H₁-Receptor Antagonist
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Buclizine Analysis and Forecast
12.1 Introduction
12.2 Latin America Buclizine Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Buclizine Market Size Forecast by Type
12.6.1 Hospital
12.6.2 Drug Store
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Buclizine Market Size Forecast by Applications
12.10.1 Antiallergic Agent
12.10.2 Histamine H₁-Receptor Antagonist
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Buclizine Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Buclizine Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Buclizine Market Size Forecast by Type
13.6.1 Hospital
13.6.2 Drug Store
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Buclizine Market Size Forecast by Applications
13.10.1 Antiallergic Agent
13.10.2 Histamine H₁-Receptor Antagonist
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Buclizine Market: Competitive Dashboard
14.2 Global Buclizine Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Stuart Pharmaceuticals
14.3.2 Laboratorios Rocnarf
14.3.3 UCB
14.3.4 Mankind Pharma
14.3.5 Johnson and Johnson
14.3.6 Meider Pharma
14.3.7 Sanofi
14.3.8 MK Pharma
14.3.9 HUA Shin Chemical Pharmaceutical
14.3.10 Peili Pharmaceutical
14.3.11 Pfizer
14.3.12 Sinphar
14.3.13 Al Pharm
